BioSpace News Archive

Sectra (STO: SECT B) has received a 510(k) clearance by the US Food & Drug Administration (FDA). The clearance applies for Sectra Digital Pathology Module, the key component of Sectra’s pathology solution, when used together with Leica Biosystems’ scanner AT2 D

Company Continues to Leverage its Real-World Evidence Data Capabilities and Strengthens Position as Limited Distribution Specialty Pharmacy Provider FRISCO, Texas--( BUSINESS WIRE )-- Soleo Health , an innovative national provider of complex specialty pharmacy and infusion services, announced today it has been selected by Grifols , a global healthcare company dedicated to enhancing the health and well-being of people around the world, as one of th

Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients Company launches expanded content to detect novel NTRK, ALK, RET and BRAF fusions at time of diagnosis SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Veracyte, Inc. (Nasdaq: VCYT) today announced results of a study that identified over 100 novel or rare NTRK, ALK, RET and BRAF fusions in

Corcept Therapeutics Incorporated today announced the publication of an abstract in the April-May supplemental issue of the Journal of the Endocrine Society (JES). The abstract describes the Phase 3 trial (entitled “GRADIENT”) of relacorilant in

American Regent, Inc., a U.S. manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio , announced today that it will acquire Daiichi Sankyo Altkirch SARL, a Daiichi Sankyo company that has an Active Pharmaceutical Ingredient (API) pharmaceutical manufacturing plant in Altkirch, F

Healthcare Integrated Technologies, Inc. (“HITC”) is pleased to update our shareholders with a brief overview of the key initiatives we have successfully completed over the past two years.

During April, IBS Awareness Month, biotech company Glycom is offering a free trial offer of Holigos® IBS Restore for people suffering from abdominal pain, bloating, constipation or diarrhea caused by irritable bowel syndrome (IBS). Patients with IBS will need to reach out to their healthcare professionals to obtain their free product sample.

Production, New Orders, and Employment Contracting; Supplier Deliveries Slowing at Faster Rate; Backlog Contracting; Raw Materials Inventories Contracting; Customers’ Inventories Too Low; Prices Decreasing; Exports and Imports Contracting

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced the expansion of their renowned Certified Duchenne Care Center Program (CDCCP) with the program’s second Adult Certified Duchenne Care Center and first dually-certified center, the clinic at Kennedy Krieger Institute.

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing onvansertib for the treatment of various cancers including colorectal, prostate and leukemia, announced today that its Phase 1b /2 clinical trial of onvansertib in combination with standard-of-care FOLFIRI/Avastin® (bevacizumab) for second-line t